FDA Inspection
Nang Kuang Pharmaceutical Co., Ltd.Nang Kuang Pharmaceutical Co., Ltd. – FDA Inspection, Nov 6, 2018
Record Details
This FDA Inspection record concerns Nang Kuang Pharmaceutical Co., Ltd., with an inspection on November 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Rita K. Vick (Issuing Officer)
View Company Profile
ID · e0c250ef-e31d-4a25-aee0-c55d5635d5a4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1072749
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Nang Kuang Pharmaceutical Co., Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2024 | Not classified | Office of Inspections and Investigations | |
| April 2, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 5, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nang Kuang Pharmaceutical Co., Ltd.
- FDA Inspection 1260207 - 2024-11-07
- FDA Inspection 1236762 - 2024-04-02
- FDA Inspection 1024786 - 2017-09-05
- FDA Inspection 923879 - 2015-04-24
- FDA Inspection 851643 - 2013-08-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.